Research Insight

A new technique has been developed utilizing nanotechnology to detect disease biomarkers in the form of nucleic acids.The proof-of-concept study came from a team of researchers at Wake Forest Baptist Medical Center The proof-of-concept...

Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to develop an oral cholera vaccine. The collaboration was established to fast track...

Amgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA accepted Biologics License Application (BLA) for evolocumab, an investigational fully human monoclonal antibody that...

Japan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic fibrosis. Hepatic fibrosis is an important factor in the diagnosis and treatment of liver diseases. Terms of the agreement...

exscientia Ltd. the polypharmacology driven drug discovery company announced today that they have signed an agreement with Sunovion Pharmaceuticals Inc. to collaborate on the discovery and optimisation of novel medicines for psychiatric disorders. ...

British-Swedish drugmaker AstraZeneca has received approval from US Food and Drug Administration (FDA) for its once-daily Xigduo XR to treat adult patients with type 2 diabetes. Xigduo XR is a combination of two...

US-based drugmaker Pfizer has received accelerated approval from US Food and Drug Administration (FDA) for its Trumenba to treat Meningococcal B disease in adolescents and young adults. As part of the breakthrough therapy designation...